Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 1.8. It has been cited 73 times, with 67 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
1.1
From 55 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 67 citers.
USAMRMC/CDMRP
Grant: W81XWH170141
Diana Princess of Wales endowed Professorship and LCCTRAC funds from the Robert H. Lurie Comprehensive Cancer Center
Grant: N/A
National Cancer Institute
Grant: NCI CCSG P30 CA060553
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
Fields of Study
Keywords
Sustainable Development Goals